The online version of this article (https://doi.org/10.1007/s13300-018-0457-6) contains supplementary material, which is available to authorized users.
To view enhanced digital features for this article, go to https://doi.org/10.6084/m9.figshare.6397025.
This article evaluates the potential long-term effect of two different color indication methods for self-monitoring of blood glucose (SMBG), the color record (CR) and color display (CD), on metabolic parameters in insulin-treated type 2 diabetes in a post-intervention period.
101 participants with type 2 diabetes who completed the Color IMPACT study were enrolled in a 2-year comparison follow-up study. Participants continued SMBG with their usual diabetes care. The study outcomes were differences in change in HbA1c levels, blood pressure (BP), body weight and lipid profiles between the CR and non-CR arms and the CD and non-CD arms during a 1- and 2-year period of the study.
98 participants were analyzed. Reductions in HbA1c levels, systolic BP and low-density lipoprotein cholesterol levels were maintained in the CR arm by − 0.40% (95% CI: − 0.73 to − 0.06, p = 0.020), −1 3.2 mmHg (95% CI: − 24.1 to − 2.3, p = 0.019), − 11.4 mg/dl (95% CI: − 18.1 to − 4.6, p = 0.001), respectively, in a 1-year period. However, HbA1c and BP returned to the baseline levels during an additional 1-year period. In contrast, there were no significant changes in outcome in the CD arm during the study period.
Intervention promoting self-action such as the color record method in SMBG sustains a beneficial effect on metabolic parameters after the intervention. This long-term effect is helpful for people with type 2 diabetes to manage their diabetes ABCs (HbA1c, BP, cholesterol) and to prevent diabetic complications.
UMIN clinical trials registry identifier, UMIN000006865.
Supplementary material 1 (PDF 396 kb)13300_2018_457_MOESM1_ESM.pdf
American Diabetes Association. Standards of medical care in diabetes–2018. Diabetes Care. 2018;41:S1–159. CrossRef
Yu SH, Kang JG, Hwang YC, et al. Increasing achievement of the target goals for glycemic, blood pressure and lipid control for adults with diagnosed diabetes in Korea. J Diabetes Invest. 2013;4:460–5. CrossRef
Janghorbani M, Papi B, Amini M. Current status of glucose, blood pressure and lipid management in type 2 diabetes clinic attendees in Isfahan, Iran. J Diabetes Invest. 2015;6:716–25. CrossRef
AADE. AADE7 self-care behaviors. Diabetes Educ. 2008;34:445–9. CrossRef
International Diabetes Federation. Global guideline for type 2 diabetes. Available from: https://www.idf.org/e-library/guidelines.html. Accessed 10 Jul 2017.
Harashima S-I, Fukushima T, Sasaki M, et al. Self-monitoring of blood glucose (SMBG) improves glycaemic control in oral hypoglycaemic agent (OHA)-treated type 2 diabetes (SMBG-OHA study). Diabetes Metb Res Rev. 2013;29:77–84. CrossRef
Nishimura A, Harashima SI, Fujita Y, et al. Effects of structured testing versus routine testing of blood glucose in diabetes self-management: a randomized controlled trial. J Diabetes Complic. 2017;31:228–33. CrossRef
Committee Canadian Diabetes Association Clinical Practice Guideline Expert. Canadian Diabetes Association 2013 Clinical Practice Guidelines. Can J Diabetes. 2013;37:S1–212. CrossRef
Knowles MS, Holton EF III, Swanson RA. The Adult Learner: the definitive classic in adult education and human resource development. 8th ed. London: Routledge; 2015.
- Long-Term Effect of the Color Record Method in Self-Monitoring of Blood Glucose on Metabolic Parameters in Type 2 Diabetes: A 2-Year Follow-up of the Color IMPACT Study
- Springer Healthcare
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II